Zura Bio Ltd (ZURA) Financial Statements
Free cash flow over the same period: -$64.9M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
ZURAZura Bio LtdFollow ZURA — free
—
Price chart with a free account
- Market cap
- 322.0M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 18 Nov, in 25 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.
| Line | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|
| Research & development | — | 44.0 | 24.4 | 42.1 | 58.4 | |
| Operating income | -2.7 | -62.6 | -55.2 | -75.2 | -92.8 | |
| Pre-tax income | — | -60.6 | -52.4 | -68.7 | -85.8 | |
| Income tax | — | 0.0 | 0.0 | — | — | |
| Net income | -25.7 | -60.4 | -52.4 | -68.7 | -85.7 | |
| Diluted EPS ($) | — | -2.09 | -0.60 | -1.06 | -0.93 | |
| Diluted shares (mn) | — | 33.1 | 75.1 | 94.2 | — |
USD millions · SEC XBRL
Zura Bio Ltd — questions
- What is Zura Bio Ltd's net income?
- -$85.7M over the twelve months to 2026-06-30.
- What is Zura Bio Ltd's free cash flow?
- -$64.9M over the twelve months to 2026-06-30.
- What are Zura Bio Ltd's diluted earnings per share?
- $-0.93 over the twelve months to 2026-06-30.
Every figure on this page comes from Zura Bio Ltd's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.